BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 453611)

  • 1. Plasma concentrations of pancuronium and neuromuscular blockade after injection into the isolated arm, bolus injection, and continuous infusion.
    Agoston S; Feldman SA; Miller RD
    Anesthesiology; 1979 Aug; 51(2):119-22. PubMed ID: 453611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma concentrations of pancuronium during predetermined intensities of neuromuscular blockade.
    Shanks CA; Somogyi AA; Triggs EJ
    Br J Anaesth; 1978 Mar; 50(3):235-9. PubMed ID: 637996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-response and plasma concentration-response relationships of pancuronium in man.
    Shanks CA; Somogyi AA; Triggs EJ
    Anesthesiology; 1979 Aug; 51(2):111-8. PubMed ID: 453610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between the continuous infusion of vecuronium and the intermittent administration of pancuronium and vecuronium.
    Noeldge G; Hinsken H; Buzello W
    Br J Anaesth; 1984 May; 56(5):473-7. PubMed ID: 6144316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Edrophonium antagonism of pancuronium-induced neuromuscular blockade in man: a reappraisal.
    Kopman AF
    Anesthesiology; 1979 Aug; 51(2):139-42. PubMed ID: 453615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromuscular blocking effects of atracurium, vecuronium and pancuronium during bolus and infusion administration.
    Gramstad L; Lilleaasen P
    Br J Anaesth; 1985 Nov; 57(11):1052-9. PubMed ID: 2864943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paralysis in the critically ill: intermittent bolus pancuronium compared with continuous infusion.
    de Lemos JM; Carr RR; Shalansky KF; Bevan DR; Ronco JJ
    Crit Care Med; 1999 Dec; 27(12):2648-55. PubMed ID: 10628604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diuretic-induced hypokalaemia, pancuronium neuromuscular blockade and its antagonism by neostigmine.
    Miller RD; Roderick LL
    Br J Anaesth; 1978 Jun; 50(6):541-4. PubMed ID: 666926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Edrophonium antagonizes combined lidocaine-pancuronium and verapamil-pancuronium neuromuscular blockade in cats.
    Carpenter RL; Mulroy MF
    Anesthesiology; 1986 Nov; 65(5):506-10. PubMed ID: 3777479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolongation of pancuronium-induced neuromuscular blockade by intravenous infusion of nitroglycerin.
    Glisson SN; El-Etr AA; Lim R
    Anesthesiology; 1979 Jul; 51(1):47-9. PubMed ID: 110176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovery from pancuronium and vecuronium administered simultaneously in the isolated forearm and the effect on recovery following administration after cross-over of drugs.
    Feldman SA; Fauvel NJ; Hood JR
    Anesth Analg; 1993 Jan; 76(1):92-5. PubMed ID: 8093426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancuronium-induced neuromuscular blockade, and its antagonism by neostigmine, at 29, 37, and 41 c.
    Miller RD; Roderick LL
    Anesthesiology; 1977 May; 46(5):333-5. PubMed ID: 851242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovery of neuromuscular function after atracurium and pancuronium maintenance of pancuronium block.
    Whalley DG; Lewis B; Bedocs NM
    Can J Anaesth; 1994 Jan; 41(1):31-5. PubMed ID: 8111941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment with pancuronium before suxamethonium administration in patients heterozygous for the usual and the atypical plasma cholinesterase gene.
    Ostergaard D; Viby-Mogensen J; Hanel HK; Skovgaard LT
    Acta Anaesthesiol Scand; 1991 Aug; 35(6):502-7. PubMed ID: 1897345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined i.v. bolus and infusion of pancuronium bromide.
    Somogyi AA; Shanks CA; Triggs EJ
    Br J Anaesth; 1978 Jun; 50(6):575-82. PubMed ID: 666932
    [No Abstract]   [Full Text] [Related]  

  • 16. Does intravenous infusion of nitroglycerin potentiate pancuronium- and vecuronium-induced neuromuscular blockade?
    Schwarz S; Agoston S; Houwertjes MC
    Anesth Analg; 1986 Feb; 65(2):156-60. PubMed ID: 2867718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of the serum concentration of pancuronium to its neuromuscular activity in man.
    Agoston S; Crul JF; Kersten UW; Scaf AH
    Anesthesiology; 1977 Dec; 47(6):509-12. PubMed ID: 337856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability of pipecuronium neuromuscular blockade.
    Diefenbach C; Mellinghoff H; Buzello W
    Acta Anaesthesiol Scand; 1993 Feb; 37(2):189-91. PubMed ID: 8383402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition kinetics of pancuronium bromide in patients with total biliary obstruction.
    Somogyi AA; Shanks CA; Triggs EJ
    Br J Anaesth; 1977 Nov; 49(11):1103-8. PubMed ID: 588390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of large dose of vecuronium with pancuronium for prolonged neuromuscular blockade.
    Rørvik K; Husby P; Gramstad L; Vamnes JS; Bitsch-Larsen L; Koller ME
    Br J Anaesth; 1988 Aug; 61(2):180-5. PubMed ID: 2901270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.